In agreement with prior findings, we found that the expression levels of NRF2 mRNA and FTH1, SLC7A11 were drastically increased in samples from patient with primary AML compared with those in HIs and patients with AML-CR. This evidence concerns the gene FTH1 and acute myeloid leukemia.